ACT-HIB

This brand name is authorized in Austria, Cyprus, Estonia, Finland, France, Hong Kong, Netherlands, New Zealand, Poland, Turkey

Active ingredients

The drug ACT-HIB contains one active pharmaceutical ingredient (API):

1 Haemophilus influenzae B
UNII FLV5I5W26R - HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN

Haemophilus influenza type B (Hib) is a bacteria responsible for severe pneumonia, meningitis and other invasive diseases almost exclusively in young children. Vaccines are the only public health tool capable of preventing the majority of serious Hib disease.

Read about Haemophilus influenzae B

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07AG01 Haemophilus influenzae B, purified antigen conjugated J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AG Haemophilus influenzae B vaccines
Discover more medicines within J07AG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1019584
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 198901
Country: FR Base de données publique des médicaments Identifier(s): 61104024
Country: HK Department of Health Drug Office Identifier(s): 37568
Country: NL Z-Index G-Standaard Identifier(s): 13901397
Country: NL Z-Index G-Standaard, PRK Identifier(s): 36471
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 6803
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100224400
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699625960022

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.